Feasibility Study of the Permeability and Uptake of Mesoporous Silica Nanoparticles across the Blood-Brain Barrier

Drug delivery into the brain is impeded by the blood-brain-barrier (BBB) that filters out the vast majority of drugs after systemic administration. In this work, we assessed the transport, uptake and cytotoxicity of promising drug nanocarriers, mesoporous silica nanoparticles (MSNs), in in vitro models of the BBB. RBE4 rat brain endothelial cells and Madin-Darby canine kidney epithelial cells, strain II, were used as BBB models. We studied spherical and rod-shaped MSNs with the following modifications: bare MSNs and MSNs coated with a poly(ethylene glycol)-poly(ethylene imine) (PEG-PEI) block copolymer. In transport studies, MSNs showed low permeability, whereas the results of the cellular uptake studies suggest robust uptake of PEG-PEI-coated MSNs. None of the MSNs showed significant toxic effects in the cell viability studies. While the shape effect was detectable but small, especially in the real-time surface plasmon resonance measurements, coating with PEG-PEI copolymers clearly facilitated the uptake of MSNs. Finally, we evaluated the in vivo detectability of one of the best candidates, i.e. the copolymer-coated rod-shaped MSNs, by two-photon in vivo imaging in the brain vasculature. The particles were clearly detectable after intravenous injection and caused no damage to the BBB. Thus, when properly designed, the uptake of MSNs could potentially be utilized for the delivery of drugs into the brain via transcellular transport.

[1]  Cecilia Sahlgren,et al.  Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment. , 2011, Current drug targets.

[2]  N. Prabhakar,et al.  Design considerations for mesoporous silica nanoparticulate systems in facilitating biomedical applications , 2014 .

[3]  Jianlin Shi,et al.  Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures , 2014, Expert opinion on drug delivery.

[4]  Weihong Tan,et al.  TAT conjugated, FITC doped silica nanoparticles for bioimaging applications. , 2004, Chemical communications.

[5]  Michael Golosovsky,et al.  Real-time monitoring of epithelial cell-cell and cell-substrate interactions by infrared surface plasmon spectroscopy. , 2010, Biophysical journal.

[6]  Yoshinobu Manome,et al.  Cell-Based in Vitro Blood–Brain Barrier Model Can Rapidly Evaluate Nanoparticles’ Brain Permeability in Association with Particle Size and Surface Modification , 2014, International journal of molecular sciences.

[7]  Sean Callanan,et al.  Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[8]  W. Pardridge.  Why is the global CNS pharmaceutical market so under-penetrated? , 2002, Drug discovery today.

[9]  Atsushi Shimojima,et al.  Organic-inorganic mesoporous nanocarriers integrated with biogenic ligands. , 2007, Small.

[10]  C. Röcker,et al.  Endo- and exocytosis of zwitterionic quantum dot nanoparticles by live HeLa cells. , 2010, ACS nano.

[11]  Simon Benita,et al.  Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. , 2008, Biomacromolecules.

[12]  A. Yu,et al.  Polystyrene nanoparticle trafficking across MDCK-II. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[13]  Warren C W Chan,et al.  Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. , 2007, Nano letters.

[14]  K. Dawson,et al.  Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics. , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[15]  Zongxi Li,et al.  Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism. , 2011, ACS nano.

[16]  Indrajit Roy,et al.  In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. , 2010, ACS nano.

[17]  P. Eklund,et al.  Rational evaluation of the utilization of PEG-PEI copolymers for the facilitation of silica nanoparticulate systems in biomedical applications. , 2014, Journal of colloid and interface science.

[18]  David J. Begley,et al.  Structure and function of the blood–brain barrier , 2010, Neurobiology of Disease.

[19]  Zhi Zhu,et al.  In vitro and in vivo studies on the transport of PEGylated silica nanoparticles across the blood-brain barrier. , 2014, ACS applied materials & interfaces.

[20]  Earl J. Bergey,et al.  Organically Modified Silica Nanoparticles Are Biocompatible and Can Be Targeted to Neurons In Vivo , 2012, PloS one.

[21]  Jayanth Panyam,et al.  Dynamics of Endocytosis and Exocytosis of Poly(D,L-Lactide-co-Glycolide) Nanoparticles in Vascular Smooth Muscle Cells , 2003, Pharmaceutical Research.

[22]  K. Jeong,et al.  Assessment of ZnO and SiO2 nanoparticle permeability through and toxicity to the blood–brain barrier using Evans blue and TEM , 2014, International journal of nanomedicine.

[23]  Stephanie E. A. Gratton,et al.  The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.

[24]  C. Lehr,et al.  Transport of Metal Oxide Nanoparticles Across Calu-3 Cell Monolayers Modelling the Air-Blood Barrier , 2011 .

[25]  T. Limnell,et al.  Mesoporous silica- and silicon-based materials as carriers for poorly water soluble drugs , 2011 .

[26]  Ralph Weissleder,et al.  Transport Of Surface‐Modified Nanoparticles Through Cell Monolayers , 2005, Chembiochem : a European journal of chemical biology.

[27]  Ling Ye,et al.  The blood-brain barrier penetration and distribution of PEGylated fluorescein-doped magnetic silica nanoparticles in rat brain. , 2010, Biochemical and biophysical research communications.

[28]  Vincent Aimez,et al.  Biosensing based on surface plasmon resonance and living cells. , 2009, Biosensors & bioelectronics.

[29]  Ying Wang,et al.  Mesoporous silica nanoparticles in drug delivery and biomedical applications. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[30]  M. Odén,et al.  Shape engineering vs organic modification of inorganic nanoparticles as a tool for enhancing cellular internalization , 2012, Nanoscale Research Letters.

[31]  Yaping Li,et al.  Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles. , 2009, Small.

[32]  Saji George,et al.  Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. , 2009, ACS nano.

[33]  Michael S Strano,et al.  Single-particle tracking of endocytosis and exocytosis of single-walled carbon nanotubes in NIH-3T3 cells. , 2008, Nano letters.

[34]  Tae-Jong Yoon,et al.  Toxicity and tissue distribution of magnetic nanoparticles in mice. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[35]  X. Wu,et al.  Nanotechnological advances for the delivery of CNS therapeutics. , 2012, Advanced drug delivery reviews.

[36]  Hwan-Jeong Jeong,et al.  Optical imaging of absorption and distribution of RITC-SiO2 nanoparticles after oral administration , 2014, International journal of nanomedicine.

[37]  Dong Chen,et al.  The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. , 2010, Biomaterials.

[38]  P. Artursson,et al.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.

[39]  K. Jain.  Nanobiotechnology-based strategies for crossing the blood-brain barrier. , 2012, Nanomedicine.

[40]  Donghoon Lee,et al.  Optical and MRI multifunctional nanoprobe for targeting gliomas. , 2005, Nano letters.

[41]  M. Yliperttula,et al.  Elucidating the Signal Responses of Multi-Parametric Surface Plasmon Resonance Living Cell Sensing: A Comparison between Optical Modeling and Drug–MDCKII Cell Interaction Measurements , 2013, PloS one.

[42]  Chung-Yuan Mou,et al.  Mesoporous silica nanoparticles as nanocarriers. , 2011, Chemical communications.